2014 05 ebsin spez cell based assays preview

European Biotechnology News Science & Industry

May 2014

PREVI EW

May '14

II Cell-based Assays

SPECIAL

SPECIAL Special: Cell-based assays Benefit from an upswing market! ➤

Publication date: May 15th, 2014

Top coverage of all the relevant topics Physiologically relevant cellular assays are increasingly used to test drug candidates or decipher complex signaling pathways. One major development in recent years has been the implementation of these assays in highthroughput systems. 3D cell-based screenings are also gaining momentum, since cells thrive better in a threedimensional microenvironment than in two-dimensional settings. Developers in biopharma in particular have discovered the advantages of cell-based assays for testing the cytotoxicity and potency of their prospects. The future in the field looks bright. Analysts have forecast sales of over US$3bn in 2018 for the market that includes cell-based assays, cell lines, related equipment and software. To meet those high hopes, the five-year academicindustry partnership StemBANCC is aiming to provide well-characterised, patient-derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable biobank. In this issue, suppliers and vendors of cellular assays and cell-assay equipment have the opportunity to present their products and services to a handpicked audience, from labs in science to CSOs in the European biotech industry.

Selling your product or service!

EuroBiotechNews offers a unique format for presenting your products and services to top-rung players throughout the European life sciences sector. This special provides the latest insights from the relevant experts, and is tailored to attract the interest of decisionmakers in research institutes and in the diagnostics, nutrition, chemicals and pharma sectors. It’s the perfect opportunity to target your specific audience and really get your message across!

Editorial Deadline 28-4-2014 Editorial Contact: Dr. Martin Laqua Tel: +49-30-264921-68 Fax: +49-30-264921-11 m.laqua@biocom.de

Booking 30-04-2014 Marketing Contact: Oliver Schnell Tel: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de

BIOCOM AG | Luetzowstr. 33-36 | D-10785 Berlin | www.biocom.de

Publication 15-05-2014 Marketing Contact: Christian Boehm Tel: +49-30-264921-49 Fax: +49-30-264921-11 c.boehm@biocom.de

Cell-based Assays Special Edition: Meet your audience!

European Biotechnology News is published in co-operation with the following organisations: European Biotechnology Net work

Europe: european-biotechnology.net

Germany: biodeutschland.org

Switzerland: swissbiotech.org

CMYK

CouncilBlue: of European 100/15/0/35 BioRegions Orange: 0/75/90/0

Belgium: edma-ivd.eu

Europe: cebr.net

Europe: eapb.org

Europe: europabio.org

Europe: ebe-biopharma.org

Ireland: ibec.ie/ibia

Norway: biotekforum.no

Denmark: danskbiotek.dk

Finland: finbio.net

The Netherlands: niaba.nl

Sweden: swedenbio.com

Spain: asebio.com

France: france-biotech.org

Hungary: hungarianbiotech.org

Belgium: bio.be

EuroBiotechNews covers the biotechnology sector of the current 28 EU member states, Norway and Switzerland.

If you would like to subscribe, please refer to Portugal: www.apbio.pt

Italy: assobiotec.it

www.eurobiotechnews.eu

Media Info 2014 Nº 3 | Volume 12 | 2013 | 10.00 € | ISSN 1618-8276 | A 60711 |

European Biotechnology News Science & Industry

The English-language European Biotechnology News reports monthly on all of the latest political, economic and technical developments in the life sciences sector in all 28 EU countries plus Switzerland and Norway. With print runs of more than 15,000 copies per issue, this magazine provides the perfect platform for pan-European marketing campaigns seeking to profit from the advantages of a huge unified economic region.

ceNTRal eUROpe

Roche given green light for breast-cancer antibody drug

Subscription prices 2013: Annual subscription companies/individuals Annual subscription students/unemployed

NORTHeRN eUROpe

Scandinavian research alliance screens for novel antibiotics Special

€ 100 € 50

European n a e p o r Eu iotechnoloNgeyws B y g BiotecEhunroolpoNeeawns lpoegayn o n h c e t o i B Antibiotics Euro News from the ocean floor BiotecEhunroolpoNegeaywns BiotechnoloNgeyws Europegayn lo EuropeanBiotechno News BiotecEhunroolopegayn News ecEhunroolpoegaywns t o i B European Biotechnology News Dates Ngey Biocapital o l II European o n BioptiteaclEhuropNeeSupplement awns Issue Special Topics und EventHighlights Booking Publication a c io B y g o l II European cEhunroopeans Euro BioFairs Compass Spring/Summer Biote 1/2 31.01.14 13.02.14 eyw N BIO-Europe Spring 2014, Turin (IT)a n B io c a p it a l e p ro g u II E chnolo s e t o i B 3 Analytica 2014, Munich (GER) 28.02.14 13.03.14 NewS P E C I A L pital pean Bioca Intellectual Property in the life sciences industry

Subscription prices incl. VAT and delivery (valid for Germany).

WeSTeRN eUROpe

Irish Public-Private Partnership ploughs D300m into research

try

Science & Indus

Mediapartners (excerpt) Analytica, BIO-Europe, BioJapan Expo, BIO tech Japan, BioSpain, CPhI Worldwide, ScanBalt Forum

Published: dustry monthly, with two SOUTHeRN eUROpe Science & In Chiesi Farmaceutici set to take double-issues per year Octo ber 2012

over Cornerstone Therapeutics

2 Oct obe r 201

eaSTeRN eUROpe

stry Science & Indu Volume: Volume 13, 2014

Gedeon Richter forms joint venture with China’s Rxmidas

2 Oct obe r 201

Cooperation Partners (excerpt) EAPB, EDMA, EuropaBio, European Biotechnology Network l a it p ca Bio II European

stry

Science & Indu

ScieNce & TecHNOlOgy

Swiss researchers map allosteric interactions of bacterial proteins

2 Oct obe r 201

stry

Science & Indu

2 Oct obe r 201

Science &

y

3 Aug ust 201

stry

Science & Indu

2 Oct obe r 201

II Euro

Co m p BioFairs April 2013

SPECIAL

stry

Science & Indu

d 1

airs Euro BioFas Coomp s

Th erapies II Genomic stic nonostsics agag d Di & Di an

September 2012

II Euro

4

SPECIA

2 Oct obe r 201

Big Data, Intellectual Property Bio IT World, Boston (USA)

L

08.08.2013

SPECIAL

02.10.2012

l_pad.indd

18:16:56 Uhr

Uhr 15:00:53

28.03.14

27 tg.indd

t 2013_

pass_Herbs

_Titel_Com

13_SPECIAL

31_EBSIN8_

2_Special_Tite

35_EBSIN10_1

5

II Guide to Events Life Sciences

stry

Science & Indu

18:16:56 Uhr

Titel_pad.ind

_12_Special_

35_EBSIN10

2 Oct obe r 201

Science & Industr

ass

02.10.2012

stry Science & Indu

2 Oct obe r 201

Industry

SPECIAL

PECIAL

S 10.04.14 11.04.2013

11:06:00 Uhr

1

Biocapital n a e p ro u E II BIO 2014, San Diego (USA) Biocapital II European

Cell-based Assays

.indd 31

PECIAL_Titel_tg

31_EBN_4_13-S

SPECIAL

18:16:56 Uhr

30.04.14

15.05.14

SPECIAL

18:16:56 Uhr

28.05.14

12.06.14

18:16:56 Uhr

04.07.14

17.07.14

29.08.14

11.09.14

26.09.14

09.10.14

02.10.2012

d 1 _Titel_pad.ind

2_Special

35_EBSIN10_1

6

l_pad.indd

2_Special_Tite

35_EBSIN10_1

7/8

1

Biocapital n a e p ro u E II Biomanufacturing, CMO´s & CRO´s CPhI Worldwide 2014, Paris (F)p e a n B io c a p it a l II Euro d 1 _Titel_pad.ind

2_Special

10

airs Euro BioFas Coomp s

Euro BioFairs Compass Autumn/Winter 35_EBSIN10_1

9

02.10.2012

BIO-Europe 2014, Frankfurt/Main (GER)

02.10.2012

September 2012

II Guide to Events Life Sciences

SPECIAL SPECIAL

18:16:56 Uhr

SPECIAL

18:16:56 Uhr

07.11.14

20.11.14

SPECIAL

18:16:56 Uhr

05.12.14

18.12.14

02.10.2012

SPECIAL

1 l_pad.indd

2_Special_Tite

35_EBSIN10_1

11

Biobased Production, EFIB 2014

02.10.2012

d 1

l_pad.ind 2_Special_Tite

35_EBSIN10_1

12

Best Innovations, Products, Technologies in 2014

02.10.2012

1 l_pad.indd

2_Special_Tite

35_EBSIN10_1

Editorial deadline for each individual issue is two workdays ahead of the booking deadline. l_pad.indd

2_Special_Tite

35_EBSIN10_1

1

02.10.2012

18:16:56 Uhr

Advertising rates: 1/1 page (4c) 1/2 page (4c) 1/3 page (4c) 1/4 page (4c) 1/8 page (4c)

>15,000

copies per month!

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

. . . . .

€ 3,600 € 2,400 € 1,950 € 1,650 € 1,350

Product information . . . . . . . . . . . . .

€ 400

(by arrangement)

Company profile:

In cooperation

20

with European biotechassociations!

1/1 page Advertorial/Company profile (4,000 characters + 1 image) . . . . . . . .

2/1 page Advertorial/Company profile (8,000 characters + 2 images) . . . . . . .

€2,500 €4,000

Job: 1/1 page b/w . . . . . . . . . . . . . . . .

1/2 page b/w . . . . . . . . . . . . . . . .

1/4 page b/w . . . . . . . . . . . . . . . .

€1,000 €500 €250

Special placement addition (e.g. cover pages) . . . . . .

€500

Inserts: 2-page . . . . . . . . . . . . . . . . . Prices on request 4-page . . . . . . . . . . . . . . . . . . . €4,000

Perfect for advertising campaigns across Europe!

Supplements: Up to 25 g . . . . . . . . . . . . . . . . . .

Up to 50 g . . . . . . . . . . . . . . . . . .

€3,000 €5,000

plus delivery charges

Geographic Coverage:

Recipients according to sector:

Region . . . . . . . . . . . . . . . . . . . . ����� Copies Western Europe (GB, IRL, F and BeNeLux,) 32 % 4,966 Central Europe (D, A and CH) . . . . . 25 % 3,880 Southern Europe (P, E, I, GR, M and CY) 13 % 2,018 Northern Europe (S, FIN, DK and NOR) . 11 % 1,708 Eastern Europe (PL, CZ, SK, HR, HUN, SLO, LIT, LET and EST) . . . . . . . . . . . . . 11 % 1,707 Other regions (USA, CDN, J and IND) . . . . . . . . . . . . . . . . . 8 % 1,241

INDUSTRY . . . . . . . . . . . . . . . . .

Companies pharma / medicine / biotechnology . . . . . . . . . . . . . . . .

Industrial large-scale production / chemistry .

Service provider / supplier / laboratory . . . .

Agriculture and food production . . . . . . .

81 %

RESEARCH . . . . . . . . . . . . . . . . .

Public-law research institutes . . . . . . . . .

Private industry research institutes . . . . . .

18 % 10 % 8 %

Circulation:

PRIVATE PERSONS / OTHER . . . . . . . .

Total print . . . . . . . . . . . . . . . . . .

Actually circulated copies . . . . . . . . . . .

Regular recipients / subscribers . . . . . . . .

I received as part of membership package . .

I as single subscriptions . . . . . . . . . . .

Complimentary copies . . . . . . . . . . . .

I of which delivered to trade fairs, congresses, cooperating companies / institutions . . . .

Archive and author copies . . . . . . . . . .

16,000 15,520 10,270 7,610 2,660 5,250

2,810 480

34 % 21 % 18 % 8 %

1 %

Recipients according to position: I Lab- / division- / unit-leaders . . . . . . . .

I Company / operating management . . . . .

I Politics / foreign trade / business development I Research / development / education . . . .

I Distribution / sales / marketing . . . . . . .

I Organisation / administration / personnel . .

I Private subscribers / other . . . . . . . . . .

25 % 16 % 15 % 15 % 11 % 10 % 8 %

Contacts: Oliver Schnell, Andreas Macht, Christian Böhm | Tel. +49 030 264921-45/-54/-49 | eMail: marketing@biocom.de